Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone
Public ClinicalTrials.gov record NCT01605084. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Phase 3B Study in HIV-Infected Individuals With Viremia on or After Their First-Line Non-Nucleoside Reverse Transcriptase Inhibitor or Integrase Inhibitor-Based Regimen and Starting a Second-Line Regimen Consisting of ATV/RTV or DRV/RTV With an Optimized NRTI Backbone
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the proportion of subjects with HIV-1 RNA \< 50 c/mL at Week 48 in patients who failed their first line therapy containing a non-nucleoside reverse transcriptase inhibitor (NNRTI) or an integrase inhibitor
Study identification
- NCT ID
- NCT01605084
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2012 (Actual)
- Primary completion
- Aug 31, 2014 (Estimated)
- Completion
- Aug 31, 2014 (Estimated)
- Last update posted
- Dec 19, 2023
2012 – 2014
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southwest Center For Hiv/Aids | Phoenix | Arizona | 85006 | — |
| Southwest Center For Hiv/Aids | Phoenix | Arizona | — | — |
| Health For Life Clinic Pllc | Little Rock | Arkansas | 72207 | — |
| Anthony M. Mills Md Inc | Los Angeles | California | 90069 | — |
| Uc Davis Medical Center | Sacramento | California | 95817 | — |
| Metropolis Medical Pc | San Francisco | California | 94109 | — |
| Indiana University Hospital | Indianapolis | Indiana | 46202 | — |
| Be Well Medical Center | Berkley | Michigan | — | — |
| Southampton Health Center | St Louis | Missouri | 63139 | — |
| Southampton Health Center | St Louis | Missouri | — | — |
| I.D. Care Associates | Hillsborough | New Jersey | 08844 | — |
| Saint Michael'S Medical Center | Newark | New Jersey | 07102 | — |
| James J Peters VAMC | The Bronx | New York | 10468 | — |
| Infectious Disease Clinic & AI | The Bronx | New York | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01605084, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 19, 2023 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01605084 live on ClinicalTrials.gov.